Clinical Trial Update: Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on neoadjuvant chemo-endocrine therapy plus immunotherapy for pre-menopausal luminal B breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED